A pilot study of antituberculous combination comparing rifabutin with rifampicin in the treatment of Human Immunodeficiency Virus-1 associated tuberculosis.
Sticht-Groh
V
V
D017088:AIDS-Related Opportunistic Infections / Q000382:microbiology*; D015497:HIV-1; D006801:Humans; D009161:Mycobacterium / Q000145:classification*; D014397:Tuberculosis, Pulmonary / Q000382:microbiology*; D014454:Uganda